Zdrowie i gospodarka · 14/01/1994
Prospective Grant of Exclusive License: Cell Stress Transcriptional Factors
The National Institutes of Health (NIH) is contemplating the grant of an exclusive world-wide license to StressTech Biomedical, Inc. for the invention embodied in U.S. Patent Application SN 07/617,910, entitled 'Cell Stress Transcriptional Factors'. The license will be royalty-bearing and limited to commercial screening assay services and kits.